Singapore: Jardiance, a diabetes drug by Boehringer Ingelheim and Eli Lilly, has demonstrated positive result in reducin...
Singapore: With an objective to bring revolution in customized knee and bone implants, Singapore's Nanyang Technological...
Singapore: Helsinn, a Swiss pharmaceutical firm focused on cancer care, has partnered with Singapore based pain drug com...
Singapore: Singapore based ASLAN Pharmaceuticals, a biotech company focused on the development of immunotherapies and ta...
Singapore: ETPL, the technology transfer arm of A*STAR, has earmarked five innovation clusters or hotspots aimed at str...
When drugs are trialed in patients, they move into a clinical setting in which the busy routine care of patients, rath...
Singapore: Nuvilex, an international biotechnology company providing cell and gene therapy solutions forthe treatment of...
Singapore: The findings are surprising, mentions BVGH, as often it is the big pharmaceutical companies that invest larg...
There are very few manufacturers in Asia capable of manufacturing antibodies on a large commercial scale. Manufacturing ...
In 2013, genetically engineered salmon will likely reach food shelves in supermarkets in the US. In a draft environmenta...
Singapore: Frost & Sullivan's APAC business analytics for healthcare providers finds that the market earned revenues...
Singapore: Ms Subhadra Devi, a nurse and senior lecturer at School of Health Sciences (Nursing) at Nanyang Polytechnic i...
Singapore: ASLAN Pharmaceuticals, Singapore based biotech company focused on the development of immunotherapies and targ...
Singapore: Researchers at A*star's Institute of Bioengineering and Nanotechnology (IBN), Singapore, have generated human...
Over the past four years, BioSpectrum Asia in association with CyberMedia Research (CMR) has been capturing the key br...
Singapore: By studying fruit flies, scientists at A*STAR's Institute of Molecular and Cell Biology (IMCB) have successfu...
Singapore: Japan's pharmaceutical company, Eisai, has established its presence in China by setting up a holding firm, Ei...
